605 related articles for article (PubMed ID: 27166089)
41. S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions.
Jiang Q; Zhang X; Dai X; Han S; Wu X; Wang L; Wei W; Zhang N; Xie W; Guo J
Nat Commun; 2022 Mar; 13(1):1548. PubMed ID: 35318320
[TBL] [Abstract][Full Text] [Related]
42. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
43. PDK1 in NF-κB signaling is a target of Xanthium strumarium methanolic extract-mediated anti-inflammatory activities.
Hossen MJ; Cho JY; Kim D
J Ethnopharmacol; 2016 Aug; 190():251-60. PubMed ID: 27286918
[TBL] [Abstract][Full Text] [Related]
44. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart.
Mora A; Sakamoto K; McManus EJ; Alessi DR
FEBS Lett; 2005 Jul; 579(17):3632-8. PubMed ID: 15961082
[TBL] [Abstract][Full Text] [Related]
45. Regulation of protein kinases in insulin, growth factor and Wnt signalling.
Pearl LH; Barford D
Curr Opin Struct Biol; 2002 Dec; 12(6):761-7. PubMed ID: 12504681
[TBL] [Abstract][Full Text] [Related]
46. Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation.
Kobayashi S; Nakamura TY; Wakabayashi S
J Mol Cell Cardiol; 2015 Jul; 84():133-42. PubMed ID: 25935310
[TBL] [Abstract][Full Text] [Related]
47. Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity.
Park S; Song J; Joe CO; Shin I
Cell Signal; 2008 Jul; 20(7):1368-74. PubMed ID: 18450422
[TBL] [Abstract][Full Text] [Related]
48. Chlorogenic Acid Targeting of the AKT PH Domain Activates AKT/GSK3β/FOXO1 Signaling and Improves Glucose Metabolism.
Gao J; He X; Ma Y; Zhao X; Hou X; Hao E; Deng J; Bai G
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30249058
[TBL] [Abstract][Full Text] [Related]
49. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
50. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
Manne BK; Münzer P; Badolia R; Walker-Allgaier B; Campbell RA; Middleton E; Weyrich AS; Kunapuli SP; Borst O; Rondina MT
J Thromb Haemost; 2018 Jun; 16(6):1211-1225. PubMed ID: 29575487
[TBL] [Abstract][Full Text] [Related]
51. Regulation of insulin secretion by geniposide: possible involvement of phosphatidylinositol 3-phosphate kinase.
Guo LX; Liu JH; Yin F
Eur Rev Med Pharmacol Sci; 2014; 18(9):1287-94. PubMed ID: 24867506
[TBL] [Abstract][Full Text] [Related]
52. GSK3 protein positively regulates type I insulin-like growth factor receptor through forkhead transcription factors FOXO1/3/4.
Huo X; Liu S; Shao T; Hua H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2014 Sep; 289(36):24759-70. PubMed ID: 25053419
[TBL] [Abstract][Full Text] [Related]
53. PKB/SGK-dependent GSK3-phosphorylation in the regulation of LPS-induced Ca2+ increase in mouse dendritic cells.
Russo A; Schmid E; Nurbaeva MK; Yang W; Yan J; Bhandaru M; Faggio C; Shumilina E; Lang F
Biochem Biophys Res Commun; 2013 Aug; 437(3):336-41. PubMed ID: 23817039
[TBL] [Abstract][Full Text] [Related]
54. The conserved role of the AKT/GSK3 axis in cell survival and glycogen metabolism in Rhipicephalus (Boophilus) microplus embryo tick cell line BME26.
de Abreu LA; Calixto C; Waltero CF; Della Noce BP; Githaka NW; Seixas A; Parizi LF; Konnai S; Vaz Ida S; Ohashi K; Logullo C
Biochim Biophys Acta; 2013 Mar; 1830(3):2574-82. PubMed ID: 23274741
[TBL] [Abstract][Full Text] [Related]
55. Endogenous IGF-I protects human intestinal smooth muscle cells from apoptosis by regulation of GSK-3 beta activity.
Kuemmerle JF
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G101-10. PubMed ID: 15297258
[TBL] [Abstract][Full Text] [Related]
56. Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.
Landis J; Shaw LM
J Biol Chem; 2014 Jun; 289(26):18603-13. PubMed ID: 24811175
[TBL] [Abstract][Full Text] [Related]
57. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells.
Mendez P; Garcia-Segura LM
Endocrinology; 2006 Jun; 147(6):3027-39. PubMed ID: 16497810
[TBL] [Abstract][Full Text] [Related]
58. Glucocorticoid-induced degradation of glycogen synthase kinase-3 protein is triggered by serum- and glucocorticoid-induced protein kinase and Akt signaling and controls beta-catenin dynamics and tight junction formation in mammary epithelial tumor cells.
Failor KL; Desyatnikov Y; Finger LA; Firestone GL
Mol Endocrinol; 2007 Oct; 21(10):2403-15. PubMed ID: 17595317
[TBL] [Abstract][Full Text] [Related]
59. Biliverdin reductase mediates hypoxia-induced EMT via PI3-kinase and Akt.
Zeng R; Yao Y; Han M; Zhao X; Liu XC; Wei J; Luo Y; Zhang J; Zhou J; Wang S; Ma D; Xu G
J Am Soc Nephrol; 2008 Feb; 19(2):380-7. PubMed ID: 18184861
[TBL] [Abstract][Full Text] [Related]
60. Human biliverdin reductase regulates the molecular mechanism underlying cancer development.
Zhang M; Xin W; Yi Z; Li Y; Liu Y; Zhang H; Chen H; Chen X; Tan S; Zhu D
J Cell Biochem; 2018 Feb; 119(2):1337-1345. PubMed ID: 28708313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
